9 completed, 5 terminated, 4 unknown, 2 withdrawn. 22 Phase 2, 7 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 22 | Completed 9, Terminated 5, Unknown 4, Withdrawn 2, Enrolling by invitation 1, Recruiting 1 |
| Phase 1 | 7 | Completed 5, Terminated 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Chorionic Gonadotropin: new trials by email Literature Review of Chorionic Gonadotropin trials Research Report on Chorionic Gonadotropin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Isotretinoin vs hCG for Male Infertility Due to Low or Absent Sperm isotretinoin, Human chorionic gonadotrophin (hCG) - Oligospermia, Azoospermia, Nonobstructive | Phase 2 | Enrolling by invitation | University of Nebraska | 100 | 2026-04-13 | 2026-04-20 |
| Efficacy of Human Chorionic Gonadotropin in Acute GVHD Treatment Human chorionic gonadotropin (hCG), Prednisone, Dexamethasone - Acute Graft Versus Host Disease | Phase 2 | Recruiting | Hospital Universitario Dr. Jose E. Gonzalez | 20 | 2025-02-01 | 2025-04-03 |
| Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids Ruxolitinib 10 MG Oral Tablet, hCG, Corticosteroids - Acute-graft-versus-host Disease | Phase 1 / Phase 2 | Terminated | Masonic Cancer Center, University of Minnesota | 10 | 2023-06-05 | 2026-03-24 |
| Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian Stimulation FE 999302, Ovitrelle, Novarel - Infertility | Phase 2 | Withdrawn | Ferring Pharmaceuticals | 2022-10-04 | 2023-01-09 | |
| Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men Lutropin alfa, Human chorionic gonadotropin - Acquired Hypogonadotropic Hypogonadism | Phase 2 | Unknown | Azienda Ospedaliero-Universitaria di Modena | 32 | 2022-01-19 | 2023-07-20 |
| ITT-5 Mechanisms of Spermatogenesis in Man Testosterone 1% Gel, Acyline, Dutasteride - Gonadotropin Deficiency | Phase 2 | Withdrawn | University of Washington | 2019-06-01 | 2019-12-18 | |
| Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility Human Chorionic Gonadotropin (hCG), Gonadotropins, GNRH-A Triptorelin - Female Infertility, Female Infertility Due to Ovulatory Disorder | Phase 1 / Phase 2 | Completed | Lebanese University | 200 | 2018-02-01 | 2023-05-09 |
| Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD Pregnyl® - Graft vs Host Disease | Phase 1 / Phase 2 | Completed | Masonic Cancer Center, University of Minnesota | 53 | 2016-03-01 | 2023-12-14 |
| GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia GnRHa/ hCG/ hMG - Azoospermia | Phase 2 | Unknown | Jinling Hospital, China | 30 | 2015-12-01 | 2016-08-02 |
| Letrozole Versus Clomiphene Citrate for Ovulation Induction in Women With Poly Cystic Ovary Syndrome ( PCOS ) Letrozole, Clomiphene citrate, hcg hormone - Anovulation, Polycystic Ovary Syndrome | Phase 2 | Unknown | mostafa gomaa hamid halawa | 110 | 2015-10-01 | 2015-09-16 |
| Human Chorionic Gonadotrophin in an Antagonist Protocol Low dose HCG, Placebo - Infertility | Phase 2 / Phase 3 | Completed | Cairo University | 60 | 2013-08-01 | 2015-02-03 |
| Muscle-Sparing Effect Of Human Chorionic Gonadotropin (hCG) During a Very Low Calorie Diet (VLCD) Human Chorionic Gonadotropin, Placebo, Low calorie diet - HCG | Phase 1 / Phase 2 | Completed | Dr. Emma's Corporation | 59 | 2011-05-01 | 2015-04-28 |
| Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With Human Menopausal Gonadotropin (HMG) in Polycystic Ovary Syndrome low dose human chorionic gonadotropin, Clomiphen citrate plus HMG - Endocrine System Diseases, Gonadal Disorders | Phase 1 / Phase 2 | Completed | Royan Institute | 10 | 2009-08-01 | 2011-07-15 |
| Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients human chorionic gonadotropin (hCG), then epoetin alfa (EPO), Saline Placebo - Stroke | Phase 2 | Terminated | Stem Cell Therapeutics Corp. | 96 | 2009-08-01 | 2011-11-29 |
| HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone Acyline, placebo hCG (no active ingredient), hCG (human chorionic gonadotropin) - Healthy Males | Phase 1 / Phase 2 | Completed | University of Washington | 59 | 2009-03-01 | 2016-01-11 |
| Replacement of Fresh Embryo Transfers (ETs) by Frozen Embryo Transfers (FETs) Using Vitrification freezing embryos by vitrification, fresh embryo transfers, buserelin - In Vitro Fertilization | Phase 1 / Phase 2 | Unknown | Yazd Research & Clinical Center for Infertility | 500 | 2008-08-01 | 2010-01-20 |
| AS900672-Enriched in Ovulation Induction AS900672-Enriched 10 microgram (mcg), AS900672-Enriched 20 mcg, AS900672-Enriched 30 mcg - Ovulation Induction | Phase 2 | Terminated | Merck KGaA, Darmstadt, Germany | 71 | 2007-12-01 | 2014-02-13 |
| A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age r-hLH + r-hFSH, r-hFSH, Recombinant Human Choriogonadotropin (r-hCG) - Infertility, Ovulation Induction | Phase 2 | Terminated | Merck KGaA, Darmstadt, Germany | 93 | 2007-11-01 | 2014-02-27 |
| A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693) corifollitropin alfa, recombinant Follicle Stimulating Hormone (recFSH), human Chorion Gonadotropin (hCG) - Ovulation Induction | Phase 2 | Terminated | Organon and Co | 8 | 2007-05-15 | 2024-06-17 |
| Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART) AS900672-Enriched 50 microgram (mcg), AS900672-Enriched 100 mcg, AS900672-Enriched 150 mcg - Infertility | Phase 2 | Completed | Merck KGaA, Darmstadt, Germany | 520 | 2007-01-01 | 2014-02-13 |
Showing 20 of 22. Sign in to see all of them.
Infertility (8) · Polycystic Ovary Syndrome (3) · Azoospermia, Nonobstructive (2) · Hypogonadism (2) · Infertility, Male (2) · Anovulation (1) · Azoospermia (1) · Endocrine System Diseases (1) · Endometriosis (1) · Endometritis (1) · Gonadal Disorders (1) · Graft vs Host Disease (1) · Helping Behavior (1) · Hypertrichosis congenital generalized X-linked (1) · Infertility, Female (1)
Merck KGaA, Darmstadt, Germany (3) · Masonic Cancer Center, University of Minnesota (2) · Organon and Co (2) · University of Washington (2) · Azienda Ospedaliero-Universitaria di Modena (1) · Cairo University (1) · Dr. Emma's Corporation (1) · Ferring Pharmaceuticals (1) · Hadassah Medical Organization (1) · Hospital Universitario Dr. Jose E. Gonzalez (1) · Jinling Hospital, China (1) · Lebanese University (1) · Royan Institute (1) · Stem Cell Therapeutics Corp. (1) · University of Nebraska (1)
United States (8) · Iran (2) · Spain (2) · Canada (1) · China (1) · Egypt (1) · India (1) · Israel (1) · Italy (1) · Lebanon (1) · Mexico (1) · Switzerland (1)
Antonio Pellicer, Professor Dr (1) · Assaf Ben-Meir, MD (1) · Bing Yao, MD (1) · Chris Deibert, MD, MPH (1) · Mahnaz Ashrafi (1) · Mara Roth, MD (1) · Michael D Hill, MD (1) · Nehman Makdissy, Professor (1) · Samar El Hamoui, Dr (1) · Sherman Holtan, MD (1) · Shernan Holtan, MD (1) · Steven C Cramer, MD (1) · William Bremner, MD, PhD (1)
PMID 15126522, PMID 20373015, PMID 20484472, PMID 23040523, PMID 24588854, PMID 30243299, PMID 32236525, PMID 37279855
U54HD012629 (1)